Ultralife Corporation
ULBI
$7.59
-$0.07-0.85%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.24% | 12.94% | 5.86% | 2.74% | 3.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.24% | 12.94% | 5.86% | 2.74% | 3.66% |
| Cost of Revenue | 18.76% | 16.27% | 8.34% | 3.35% | 2.26% |
| Gross Profit | 8.95% | 3.54% | -1.14% | 0.96% | 7.94% |
| SG&A Expenses | 25.38% | 26.62% | 21.24% | 18.43% | 14.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.21% | 18.50% | 10.99% | 6.45% | 4.48% |
| Operating Income | -55.80% | -55.59% | -51.90% | -39.87% | -9.19% |
| Income Before Tax | -201.17% | -78.91% | -64.21% | -45.88% | -8.95% |
| Income Tax Expenses | -229.33% | -69.99% | -49.40% | -36.99% | -3.02% |
| Earnings from Continuing Operations | -192.85% | -80.78% | -67.55% | -48.26% | -10.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 154.64% | 51.43% | -600.00% | -437.93% | -412.90% |
| Net Income | -193.44% | -80.89% | -68.24% | -49.34% | -12.30% |
| EBIT | -55.80% | -55.59% | -51.90% | -39.87% | -9.19% |
| EBITDA | -27.11% | -33.43% | -34.65% | -27.27% | -4.67% |
| EPS Basic | -192.53% | -81.11% | -68.67% | -50.30% | -13.65% |
| Normalized Basic EPS | -79.64% | -83.42% | -69.95% | -51.35% | -12.45% |
| EPS Diluted | -194.08% | -81.95% | -69.17% | -50.06% | -12.01% |
| Normalized Diluted EPS | -79.55% | -83.24% | -69.73% | -51.69% | -13.27% |
| Average Basic Shares Outstanding | 0.53% | 0.93% | 1.50% | 2.06% | 2.11% |
| Average Diluted Shares Outstanding | -0.51% | 0.07% | 1.28% | 2.59% | 2.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |